Search for a trial

Phase II study of Cetuximab combined with Cisplatin or Carboplatin/Pemetrexed as first line treatment in patients with malignant pleural mesothelioma

By adding Cetuximab to standard treatment, we hope to prolonge progression free survival

CLE in diagnosing pleural malignancies, a comparison with pathology

To describe criteria on CLE-imaging of different entities (thoracic wall/ pleura/ fibrosis/ mediastinum) compared to histology.